RISK OF CENTRAL SEROUS CHORIORETINOPATHY IN ADULTS PRESCRIBED ORAL CORTICOSTEROIDS: A Population-Based Study in Taiwan
暂无分享,去创建一个
Shih-Jen Chen | W. Chan | Shing‐Jong Lin | Jaw-Wen Chen | H. Leu | P. Chou | Po‐Hsun Huang | D. Tsai | Chin‐Chou Huang | Chia-Min Chung | Tseng-Ji Chen | Chin-Chou Huang | Shing-Jong Lin | Jaw-wen Chen
[1] Shih-Jen Chen,et al. Increased risk of erectile dysfunction among males with central serous chorioretinopathy – a retrospective cohort study , 2013, Acta ophthalmologica.
[2] Hong Wang,et al. Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001–2006: A Population-based Study , 2013, PloS one.
[3] Shih-Jen Chen,et al. Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study , 2012, British Journal of Ophthalmology.
[4] Yuh-Min Chen,et al. Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. , 2012, American journal of ophthalmology.
[5] L. Yannuzzi. TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.
[6] C. S. Lee,et al. CENTRAL SEROUS CHORIORETINOPATHY AFTER RENAL TRANSPLANTATION , 2011, Retina.
[7] A. Caccavale,et al. Central serous chorioretinopathy: a pathogenetic model , 2011, Clinical ophthalmology.
[8] E. Suhler,et al. The Dilemma of Central Serous Retinopathy, a Corticosteroid-induced Complication, in Patients with Ocular Inflammatory Disease , 2010, The Journal of Rheumatology.
[9] Herng‐Ching Lin,et al. Neovascular Age-Related Macular Degeneration and the Risk of Stroke: A 5-Year Population-Based Follow-Up Study , 2010, Stroke.
[10] Retinal vein occlusion and the risk of acute myocardial infraction: a 3-year follow-up study , 2009, British Journal of Ophthalmology.
[11] J. Pulido,et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. , 2008, Ophthalmology.
[12] R. Chervin,et al. Central serous chorioretinopathy and risk for obstructive sleep apnea , 2007, Sleep and Breathing.
[13] E. Bouzas,et al. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[14] D. Gagnon,et al. Risk factors for central serous chorioretinopathy: a case-control study. , 2004, Ophthalmology.
[15] A. Eller,et al. Serous retinal detachment resembling central serous chorioretinopathy following organ transplantation , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.
[16] T. Hikichi,et al. Features of abnormal choroidal circulation in central serous chorioretinopathy , 2003, The British journal of ophthalmology.
[17] L. Yannuzzi,et al. Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.
[18] C. Pournaras,et al. Central Serous Chorioretinopathy and Glucocorticoids , 2022 .
[19] P. Massin,et al. [Central serous chorioretinopathy and systemic steroid therapy]. , 2001, Journal francais d'ophtalmologie.
[20] S. Kishi,et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. , 1999, Retina.
[21] J. Slakter,et al. Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.
[22] M. Wakakura,et al. Corticosteroid-induced central serous chorioretinopathy. , 1997, Japanese journal of ophthalmology.
[23] J. Slakter,et al. Central serous chorioretinopathy in younger and older adults. , 1996, Ophthalmology.
[24] S. Fine,et al. Choroidopathy in systemic lupus erythematosus. , 1988, Archives of ophthalmology.
[25] M. Wakakura,et al. Central serous chorioretinopathy complicating systemic corticosteroid treatment. , 1984, The British journal of ophthalmology.